These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10556663)

  • 41. [Monoclonal cryoglobulin with antinuclear activity and S-chain fragment in Waldenström's disease].
    Hufnagl HD; Schwarz JA; Jost H; Scheurlen PG
    Verh Dtsch Ges Inn Med; 1973; 79():348-50. PubMed ID: 4208218
    [No Abstract]   [Full Text] [Related]  

  • 42. [Monoclonal IgM interference with immunoturbidimetric determination of ferritin and transferrin].
    Roszyk L; Faye B; Tournilhac O; Fogli A; Sapin V
    Ann Biol Clin (Paris); 2007; 65(6):659-62. PubMed ID: 18039612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoimmune thrombocytopenia in Waldenström's macroglobulinemia.
    Owen RG; Lubenko A; Savage J; Parapia LA; Jack AS; Morgan GJ
    Am J Hematol; 2001 Feb; 66(2):116-9. PubMed ID: 11421289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Secondary biochemical syndrome and IgM hypermacroglobulinemia in Waldenström's disease].
    Mebazaa A; Ollier MP; Degrelle H; Lazar P; Filitti-Wurmser S; Hartmann L
    Ann Biol Clin (Paris); 1970; 28(1):25-40. PubMed ID: 4986988
    [No Abstract]   [Full Text] [Related]  

  • 45. Waldenström's macroglobulinemia associated with a mixed cryoglobulin. Report of a case with partial precipitation in vitro at 37 degrees C.
    Keshgegian AA; Sevin P
    Arch Pathol Lab Med; 1979 Jun; 103(6):270-3. PubMed ID: 110284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatment.
    Rudnicki SA; Harik SI; Dhodapkar M; Barlogie B; Eidelberg D
    Neurology; 1998 Oct; 51(4):1210-3. PubMed ID: 9781565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic calcific pancreatitis in a patient with Waldenstrom's macroglobulinemia.
    Hertan HI; Pitchumoni CS
    Am J Gastroenterol; 1991 May; 86(5):633-4. PubMed ID: 1903025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigenic heterogeneity among monoclonal IgM: observations on guinea-pig sera.
    Wollheim FA; Hansson GL
    Experientia; 1975 Oct; 31(10):1229-30. PubMed ID: 812725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flare in neuropathy following rituximab therapy for Waldenstrom's macroglobulinemia.
    Noronha V; Fynan TM; Duffy T
    J Clin Oncol; 2006 Jan; 24(1):e3. PubMed ID: 16382111
    [No Abstract]   [Full Text] [Related]  

  • 50. IgG monoclonal gammapathy in the sister of a patient with Waldenström's macroglobulinaemia.
    Fine JM; Lambin P; Valentin L; Blatrix C
    Biomedicine; 1973 Mar; 19(3):117-21. PubMed ID: 4125987
    [No Abstract]   [Full Text] [Related]  

  • 51. Response of Waldenstrom's macroglobulinemia to pentostatin (2'-deoxycoformycin).
    Riddell S; Johnston JB; Rayner HL; Israels LG
    Cancer Treat Rep; 1986 Apr; 70(4):546-8. PubMed ID: 3084084
    [No Abstract]   [Full Text] [Related]  

  • 52. Waldenström's macroglobulinemia-associated retinopathy.
    Sen HN; Chan CC; Caruso RC; Fariss RN; Nussenblatt RB; Buggage RR
    Ophthalmology; 2004 Mar; 111(3):535-9. PubMed ID: 15019332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alleviation of IgM monoclonal protein interference in nephelometric assays by sample treatment with reducing agent in a chaotropic salt solution.
    Schnebelen A; Sweat K; Marshall J; Bornhorst J
    Am J Clin Pathol; 2012 Jan; 137(1):26-8. PubMed ID: 22180475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two IgM paraproteins differing in carbohydrate content in a patient with Waldenström's macroglobulinemia.
    Virella G; Lechner MC
    Clin Chim Acta; 1976 Mar; 67(2):137-44. PubMed ID: 813915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Waldenström's macroglobulinemia developing in a patient with multiple sclerosis: coincidence or association?
    Deftereos S; Farmakis D; Papadogianni A; Besleme B; Diamanti-Kandarakis E; Polymeropoylos E; Georgonikou D; Aessopos A
    Mult Scler; 2004 Oct; 10(5):598-600. PubMed ID: 15471380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia.
    Gertz MA; Kyle RA; Noel P
    J Clin Oncol; 1993 May; 11(5):914-20. PubMed ID: 8487054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Waldenström's macroglobulinemia with an uncommon presentation].
    Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
    Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunoglobulin levels in the serum of patients with myeloma and Waldenström's macroglobulinemia].
    Linz R; Lecocq E
    C R Seances Soc Biol Fil; 1971; 165(5):1191-4. PubMed ID: 4261510
    [No Abstract]   [Full Text] [Related]  

  • 59. [Faulty haemoglobin values in Sia-positive Waldenström's macroglobulinaemia (author's transl)].
    Gelinsky P; Braun HJ; Bohner J; Schoeler M
    Dtsch Med Wochenschr; 1974 Feb; 99(7):283-6. PubMed ID: 4206457
    [No Abstract]   [Full Text] [Related]  

  • 60. [Waldenström's macroglobulinemia--the experts opinion about new therapeutic possibilities and response criteria].
    Jurczyszyn A; Skotnicki AB
    Pol Arch Med Wewn; 2004 Sep; 112(3):1113-21. PubMed ID: 15727094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.